Positron Emission Tomography in Schizophrenic Patients with and without Neuroleptic Medication
Open Access
- 29 June 1985
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 5 (2) , 201-206
- https://doi.org/10.1038/jcbfm.1985.26
Abstract
Positron emission tomography using [18F]2-fluoro-2-deoxy-d-glucose was performed in nine chronic schizophrenic patients both when medication-free and when medicated with neuroleptics. Total brain cortex, temporal cortex, and basal ganglia glucose use was significantly increased with medication; however, there was no change in anterior/posterior metabolic gradients.Keywords
This publication has 16 references indexed in Scilit:
- Clinical correlates of decreased anteroposterior metabolic gradients in positron emission tomography (PET) of schizophrenic patientsAmerican Journal of Psychiatry, 1985
- Anteroposterior Gradients in Cerebral Glucose Use in Schizophrenia and Affective DisordersArchives of General Psychiatry, 1984
- Human sensory stimulation and deprivation: Positron emission tomographic results and strategiesAnnals of Neurology, 1984
- Prospects for both precision and accuracy in positron emission tomographyAnnals of Neurology, 1984
- Patterns of metabolic activity in the treatment of schizophreniaAnnals of Neurology, 1984
- Distribution of effects of haloperidol on energy metabolism in the rat brainBrain Research, 1982
- Cerebral Glucography With Positron TomographyArchives of General Psychiatry, 1982
- Antipsychotic Drugs, Neurotransmitters, and SchizophreniaAmerican Journal of Psychiatry, 1978
- DISTRIBUTION OF CEREBRAL ACTIVITY IN CHRONIC SCHIZOPHRENIAThe Lancet, 1974
- ABNORMALITIES OF CEREBRAL BLOOD FLOW DISTRIBUTION IN PATIENTS WITH CHRONIC SCHIZOPHRENIAActa Psychiatrica Scandinavica, 1974